2022-12-11
2022-11-15
2022-11-25
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2022-12-11
2023-02-03
2023-09-07
2022-12-07
肺癌联合疗法77%疾病控制率、多款基因/RNA疗法步入临床…
2023-01-09
致力于自主可控的新型基因编辑,齐禾生科完成超亿元Pre-A轮融资
2023-04-20
超越“基因魔剪”CRISPR-Cas9,碱基编辑治疗特殊贫血症显优势
2023-07-05
2023-01-01